[1] |
Watts RA,Scott DG. Recent developments in the classification and assessment of vasculitis[J]. Best Pract Res Clin Rheumatol, 2009, 23(3):429-443.
|
[2] |
朱琦,丁雯瑾,房静远,等.以消化道表现为首发症状的抗中性粒细胞胞质抗体相关性小血管炎2例[J].胃肠病学,2006,11(10):637-638.
|
[3] |
Joy MS,Hogan SL,Jennette JC, et al. A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis[J]. Nephrol Dial Transplant, 2005, 20(12):2725-2732.
|
[4] |
Deniz K,Ozşeker HS,Balas S, et al. Intestinal involvement in Wegener's granulomatosis[J]. J Gastrointestin Liver Dis, 2007, 16(3):329-331.
|
[5] |
Sinico RA,Bottero P. Churg-Strauss angiitis[J]. Best Pract Res Clin Rheumatol, 2009, 23(3):355-366.
|
[6] |
Basu N,Mcclean A,Harper L, et al. Explaining fatigue in ANCA-associated vasculitis[J].Rheumatology, 2013, 52(9):1680-1685.
|
[7] |
李毅,张燕,赵明,等.抗中性粒细胞胞浆抗体相关性血管炎患者血清C反应蛋白水平及临床意义[J].临床肾脏病杂志,2014,14(4):226-229.
|
[8] |
Lionaki S,Blyth ER,Hogan SL, et al. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis[J].Arthritis Rheum, 2012, 64(10):3452-3462.
|
[9] |
夏正坤,周青山,高远赋,等.抗中性粒细胞胞浆抗体相关性血管炎诊治策略[J].临床儿科杂志,2016,34(6):401-405.
|
[10] |
周必业,魏世辉.Eales病患者血清中PR3-ANCA和MPO-ANCA的检测和临床意义//中国中西医结合学会眼科专业委员会第十四届学术年会暨海峡两岸眼科学术交流会论文汇编[C].福建:平潭,2015:139-143.
|
[11] |
Jayne D. The diagnosis of vasculitis[J]. Best Pract Res Clin Rheumatol, 2009, 23(3):445-453.
|
[12] |
Wallace ZS,Lu N,Unizony S, et al. Improved survival in granulomatosis with polyangiitis: a general population-based study[J]. Semin Arthritis Rheum, 2016, 45(4):483-489.
|
[13] |
Lourdudoss C,Vollenhoven RV. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center[J]. Lupus, 2014, 23(3):299-304.
|
[14] |
Yamada H. Novel strategy for the treatment of refractory vasculitis syndrome[J]. Ann Vasc Dis, 2013, 6(1):22-26.
|
[15] |
Guillevin L,Pagnoux C,Karras A, et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis[J]. N Engl J Med, 2014, 371(19):1771-1780.
|
[16] |
Lally L,Spiera R. B-cell-targeted therapy in systemic vasculitis[J]. Curr Opin Rheumatol, 2016, 28(1):15-20.
|
[17] |
Núñez Cuadros E,Galindo Zavala R,Díaz Cordovés-Rego G, et al. [Are anti-TNF-αagents really useful in systemic vasculitis? Experience in polyarteritis nodosa][J]. An Pediatr, 2015, 83(5):350-352.
|